PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA.\', \'Department of Immunobiology and the University of Arizona Center on Aging, The University of Arizona, Tucson, AZ, USA.\', \'Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA; Department of Physiology, The University of Arizona, Tucson, AZ, USA.\', \'Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.\', \'Division of Cardiothoracic Surgery, University of Arizona, Tucson, AZ, USA.\', \'Department of Immunobiology and the University of Arizona Center on Aging, The University of Arizona, Tucson, AZ, USA; BIO5 Institute, The University of Arizona, Tucson, AZ, USA.\', \'Department of Physiology, The University of Arizona, Tucson, AZ, USA.\', \'Department of Immunobiology and the University of Arizona Center on Aging, The University of Arizona, Tucson, AZ, USA; Department of Molecular & Cellular Biology, The University of Arizona, Tucson, AZ, USA; Cancer Biology Graduate Interdisciplinary Program, The University of Arizona, Tucson, AZ, USA; BIO5 Institute, The University of Arizona, Tucson, AZ, USA.\', \'Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA; Department of Physiology, The University of Arizona, Tucson, AZ, USA; BIO5 Institute, The University of Arizona, Tucson, AZ, USA. Electronic address: jchurko@arizona.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-6711(21)00436-710.1016/j.stemcr.2021.08.018
?:hasPublicationType
?:journal
  • Stem cell reports
is ?:pmid of
?:pmid
?:pmid
  • 34525378
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.0
?:rankingScore_hIndex
  • 44
is ?:relation_isRelatedTo_publication of
?:title
  • Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34525378>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34525378>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all